Showing results (511-520 of 586) with videos related to

Sort By:
Pageof 59
The Journal of Nutrition|May 25, 2012
A Period 2 genetic variant interacts with plasma SFA to modify plasma lipid concentrations in adults with metabolic syndromeAntonio Garcia-Rios, Pablo Perez-Martinez, Javier Delgado-Lista, et al.
Atherosclerosis|August 7, 2023
Association between telomere length and intima-media thickness of both common carotid arteries in patients with coronary heart disease: From the CORDIOPREV randomized controlled trialAna Ojeda-Rodriguez, Juan F Alcala-Diaz, Oriol Alberto Rangel-Zuñiga, et al.
The British Journal of Nutrition|March 6, 2010
Dietary fat modifications and blood pressure in subjects with the metabolic syndrome in the LIPGENE dietary intervention studyHanne L Gulseth, Ingrid M F Gjelstad, Audrey C Tierney, et al.
International Journal of Surgery (London, England)|March 13, 2023
Clinical outcomes and quality of life after contemporary isolated coronary bypass grafting: a prospective cohort studySigrid Sandner, Martin Misfeld, Etem Caliskan, et al.
Lancet (London, England)|September 2, 2017
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trialRobert P Giugliano, Terje R Pedersen, Jeong-Gun Park, et al.
The American Journal of Clinical Nutrition|December 6, 2008
Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated statesPablo Perez-Martinez, Dolores Corella, Jian Shen, et al.
Clinical Nutrition (Edinburgh, Scotland)|October 25, 2012
Gene-nutrient interactions on the phosphoenolpyruvate carboxykinase influence insulin sensitivity in metabolic syndrome subjectsPablo Perez-Martinez, Antonio Garcia-Rios, Javier Delgado-Lista, et al.
Cardiovascular Diabetology|March 17, 2024
Telomere length as biomarker of nutritional therapy for prevention of type 2 diabetes mellitus development in patients with coronary heart disease: CORDIOPREV randomised controlled trialAna Ojeda-Rodriguez, Oriol A Rangel-Zuñiga, Antonio P Arenas-de Larriva, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 25, 2019
Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 StudiesHyun Cheol Chung, Sarina A Piha-Paul, Jose Lopez-Martin, et al.
Plos One|June 16, 2011
Glucokinase regulatory protein genetic variant interacts with omega-3 PUFA to influence insulin resistance and inflammation in metabolic syndromePablo Perez-Martinez, Javier Delgado-Lista, Antonio Garcia-Rios, et al.
Pageof 59